Looking for Ivacaftor found 14 matches
|
Links Link to Drug Section  Link to document |
|
MHRA: Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing (03.07)
|
|
MHRA: Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing (03.07)
|
|
MHRA: Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing (03.07)
|
|
MHRA: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor): risk of psychological side effects (03.07)
|
|
NHSE: Clinical Commissioning Policy: Ivacaftor for Cystic Fibrosis (named mutations) (03.07)
|
|
NICE TA988: Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis (03.07)
|
|
NICE TA988: Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis (03.07)
|
|
NICE TA988: Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis (03.07)
|
|
NICE: Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people aged 6 years and over [ID6372] (03.07)
|
| Document Library Items Found |
|
|
